Sivia Capital Partners LLC lessened its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 40.3% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,797 shares of the healthcare conglomerate's stock after selling 1,213 shares during the period. Sivia Capital Partners LLC's holdings in UnitedHealth Group were worth $561,000 as of its most recent SEC filing.
Several other institutional investors also recently added to or reduced their stakes in the stock. Citizens National Bank Trust Department grew its holdings in UnitedHealth Group by 1.0% during the 1st quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate's stock worth $9,368,000 after acquiring an additional 170 shares in the last quarter. Fort Washington Investment Advisors Inc. OH grew its holdings in UnitedHealth Group by 0.3% during the 1st quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate's stock worth $277,641,000 after acquiring an additional 1,465 shares in the last quarter. Caitlin John LLC boosted its holdings in shares of UnitedHealth Group by 14.8% in the 1st quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate's stock valued at $451,000 after buying an additional 111 shares in the last quarter. Triumph Capital Management purchased a new position in shares of UnitedHealth Group in the 2nd quarter worth approximately $1,324,000. Finally, Focus Partners Wealth grew its position in shares of UnitedHealth Group by 5.3% in the 1st quarter. Focus Partners Wealth now owns 277,916 shares of the healthcare conglomerate's stock worth $145,559,000 after buying an additional 14,112 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.
Wall Street Analyst Weigh In
A number of research analysts have recently issued reports on the stock. UBS Group reaffirmed a "buy" rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. Bank of America lifted their price objective on shares of UnitedHealth Group from $290.00 to $325.00 and gave the stock a "neutral" rating in a research report on Monday, August 18th. Piper Sandler lowered their target price on shares of UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating for the company in a research note on Wednesday, July 30th. KeyCorp decreased their price target on shares of UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating for the company in a report on Wednesday, July 30th. Finally, Cantor Fitzgerald reaffirmed an "overweight" rating and issued a $440.00 price target on shares of UnitedHealth Group in a report on Tuesday, August 26th. Sixteen investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have given a Sell rating to the company. According to data from MarketBeat, UnitedHealth Group presently has a consensus rating of "Moderate Buy" and an average target price of $358.95.
Check Out Our Latest Analysis on UnitedHealth Group
UnitedHealth Group Stock Performance
NYSE:UNH opened at $339.57 on Wednesday. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $630.73. The stock has a market capitalization of $307.54 billion, a PE ratio of 14.71, a P/E/G ratio of 2.27 and a beta of 0.45. The company has a fifty day moving average of $293.51 and a two-hundred day moving average of $367.23. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85.
UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business had revenue of $111.62 billion for the quarter, compared to analysts' expectations of $111.75 billion. During the same period in the previous year, the company earned $6.80 EPS. UnitedHealth Group's quarterly revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.
UnitedHealth Group Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be issued a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.6%. UnitedHealth Group's dividend payout ratio is presently 38.30%.
UnitedHealth Group Company Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.